Tamoxifen-loaded liposomal topical formulation arrests hair growth in mice

British Journal of Dermatology

Volumn 163, Issue 2, 2010, Pages 412-415

  Bhatia, A ^a   Singh, B ^a   Amarji, B ^a   Katare, O P ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

hair follicle; hirsutism; liposome; oestrogen; skin

Indexed keywords

PLACEBO; TAMOXIFEN CITRATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HAIR FOLLICLE; HAIR GROWTH; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ANIMALS; BIOPSY; DRUG DELIVERY SYSTEMS; FEMALE; HAIR; HAIR FOLLICLE; LIPOSOMES; MICE; MICE, INBRED C57BL; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SKIN; TAMOXIFEN;

EID: 77954884724     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09772.x     Document Type: Article

References (34)

1. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev 2001 81 : 449 494.
2. Thornton MJ, Messenger AG, Elliott K, Randall V. Effect of androgens on the growth of cultured human dermal papilla cells derived from beard and scalp hair follicles. J Invest Dermatol 1991 97 : 345 348.
3. Randall VA, Thornton MJ, Elliott K, Messenger AG. Androgen receptors in cultured dermal papilla cells and dermal fibroblasts from scalp, beard and sexual skin. J Invest Dermatol 1989 92 : 503.
4. Ingle DJ, Baker BL. The inhibition of hair growth by estrogens as related to adrenal cortical function in the male rat. Endocrinology 1951 48 : 764 771.
5. Baumann CK, Castiglione-Gertsch M. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer. Minerva Ginecol 2009 61 : 517 539.
6. Peng J, Sengupta S, Jordan VC. Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer. Anticancer Agents Med Chem 2009 9 : 481 499.
7. Dhingra K. Antiestrogens - tamoxifen. SERMs and beyond. Invest New Drugs 1999 17 : 285 311.
8. Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum Reprod Update 2005 11 : 293 307. (Pubitemid 40674206)
9. Mitlak BH, Cohen FJ. Selective estrogen receptor modulators: a look ahead. Drugs 1999 57 : 653 663.
10. Ohnemus U, Uenalan M, Conrad F et al. Hair cycle control by estrogens: catagen induction via estrogen receptor (ER)-alpha is checked by ER beta signaling. Endocrinology 2005 146 : 1214 1225.
11. Somani N, Harrison S, Bergfeld WF. The clinical evaluation of hirsutism. Dermatol Ther 2008 21 : 376 391.
12. Mofid A, Seyyed Alinaghi SA, Zandieh S, Yazdani T. Hirsutism. Int J Clin Pract 2008 62 : 433 443.
13. Olsen EA. Evaluation and treatment of hirsutism. Introduction. Dermatol Ther 2008 21 : 313.
14. Blume-Peytavi U, Hahn S. Medical treatment of hirsutism. Dermatol Ther 2008 21 : 329 339.
15. Hu D, Hughes MA, Cherry GW. Topical tamoxifen - a potential therapeutic regime in treating excessive dermal scarring? Br J Plast Surg 1998 51 : 462 469.
16. Stevens HP, Ostlere LS, Black CM et al. Cyclical psoriatic arthritis responding to anti-oestrogen therapy. Br J Dermatol 1993 129 : 458 460.
17. Matsuoka H, Tsubaki M, Yamazoe Y et al. Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways. Exp Cell Res 2009 315 : 2022 2032.
18. Papahadjopoulos D, Kimelberg HK. Phospholipid vesicles (liposomes) as models for biological membranes. Their properties and interactions with cholesterol and proteins. Prog Surf Sci 1973 4 : 141 144.
19. Poste G, Papahadjopoulos D, Vail WJ. Lipid vesicles as carriers for introducing biologically active materials into cells. Methods Cell Biol 1976 14 : 33 71.
20. Hadgraft J. Recent developments in topical and transdermal delivery. Eur J Drug Metab Pharmacokinet 1996 21 : 165 173.
21. Cevc G. Drug delivery across the skin. Expert Opin Investig Drugs 1997 6 : 1887 1937.
22. Goyal P, Goyal K, Kumar V et al. Liposomal drug delivery systems - clinical applications. Acta Pharm 2005 55 : 1 25.
23. Ferderber K, Hook S, Rades T. Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery. J Liposome Res 2009 19 : 267 277.
24. Bhatia A, Kumar R, Katare OP. Tamoxifen entrapped topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci 2004 7 : 252 259.
25. Wolff AV, Smith PD. Compliance at the institutional and programmatic level. Lab Anim 1994 23 : 28 9.
26. James AG, Pople JE, Parish WE et al. Histological evaluation of hyperpigmentation on female Filipino axillary skin (1). Int J Cosmet Sci 2006 28 : 247 253.
27. Davies JL, Sibley JA, Myers S et al. Histological and genotypical characterization of feline cutaneous mycobacteriosis: a retrospective study of formalin-fixed paraffin-embedded tissues. Vet Dermatol 2006 17 : 155 162.
28. Ohnemus U, Uenalan M, Inzunza J et al. The hair follicle as an estrogen target and source. Endocr Rev 2006 27 : 677 706.
29. Riedel-Baima B, Riedel A. Female pattern hair loss may be triggered by low oestrogen to androgen ratio. Endocr Regul 2008 42 : 13 16.
30. Oh HS, Smart RC. An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci USA 1996 93 : 12525 12530.
31. Smart RC, Oh HS, Chanda S, Robinette CL. Effects of 17-β-estradiol and ICI 182780 on hair growth in various strains of mice. J Investig Dermatol Symp Proc 1999 4 : 285 289.
32. Chanda S, Robinette CL, Couse JF, Smart RC. 17beta-estradiol and ICI-182780 regulate the hair follicle cycle in mice through an estrogen receptor-alpha pathway. Am J Physiol Endocrinol Metab 2000 278 : E202 10.
33. Movérare S, Lindberg MK, Faergemann J et al. Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the hair follicle cycling as well as the thickness of epidermis in male mice. J Invest Dermatol 2002 119 : 1053 1058.
34. Conrad F, Paus R. Estrogens and the hair follicle. J Dtsch Dermatol Ges 2004 2 : 412 423.